Announcements Trials
Browse Landscape

Phase

Phase 2 30Phase 3 10Phase 2/3 4Phase 1 4Phase EARLY_PHASE1 1Phase 4 1Phase 1/2 1

Status

Unknown 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 3Advanced Gastric or EGJ Cancer 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × IFL protocol × Clear all
NCT03081143 2026-04-14

RAMIRIS

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2/3 Active not recruiting
429 enrolled
Gastrointestinal

Advanced Gastric or EGJ Cancer

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 2/3 Completed
124 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02942706 2021-04-30

Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Ruijin Hospital

Phase 2/3 Unknown
200 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02978313 2016-11-30

Cetuximab Monotherapy Maintenance Treatment in mCRC

Ruijin Hospital

Phase 2/3 Unknown
500 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡